The company will use the financing to expand and commercialize its self-sampling technology for remote healthcare solutions and personalized medicine.
The funding will be used to increase production capacity, develop new products, and intensify sales and marketing efforts. The investment round was led by Sciety and the network Sciety Venture Partners. Sciety and its network Sciety Venture Partners, who have invested in Capitainer for the third time since 2019.
“Thanks to the continued support from Sciety, we are able to accelerate our growth and expand our production capacity. Their expertise in life science combined with industry connections will be valuable for Capitainer as we continue to advance. We are confident that our self-sampling technology will become a game-changer in the healthcare industry, providing patients with greater convenience and accessibility while ensuring precise results,” says Christopher Aulin, CEO at Capitainer.